胰腺导管腺癌超声造影增强模式与临床预后的相关性研究
【文章页数】:2 页
【部分图文】:
图5:低増强组与等增强组生存分析图??ROC曲线??1〇'
图5:低増强组与等增强组生存分析图??ROC曲线??1〇'|?|?曲线来源???peak?(tumor)??,?sharpness?(tumorAEpeak??AEsharpness??uo?!?i?/?——?REsharpness??/?/?——锣-线??,—?J??0.6-?....
图6:超声造影时间-强度曲线参数peak_r、sharpnesst_*、AEpeak、REpeak、??AEsharpness、REsharpness区分不同增强模式可行性的ROC分析结果??35??
—.W?等《弪??0.8-?\\??r??L?\?、??V?^??0.2-??〇.〇-??I?I?I?I?I?I?I??0?200?400?600?800?1000?1200??生存期(天}??图5:低増强组与等增强组生存分析图??ROC
图7:依据peak_rCUT0FF值(45.6)分组的生存分析结果??生存函数??_???依据AEpeak分组??
图7:依据peak_rCUT0FF值(45.6)分组的生存分析结果??生存函数??1〇_???依据AEpeak分组??厂H&?老强?tAEpeak>10.1>??IK?-r-i^^^(AEpeak<10.1)??yi??\v??I?°-6-?A?—??L?6??0.2-?、??I....
图8:依据AEpeak?CUTOFF值(10.?1)分组的生存分析结果??36??
?4?组??mrk?(咖0r)??」—??eak?(tum〇r)??。,-??|。.6-?.??|?\??析?0.4-?—I??〇.2-?:??I??o.o-??I?I?I?I?I?I?I??0?200?400?600?800?1000?1200??生存期《天)??图7:依据pe....
本文编号:3960117
本文链接:https://www.wllwen.com/linchuangyixuelunwen/3960117.html